Article Details

Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201, a HER2-Targeted CAR ...

Retrieved on: 2022-09-21 07:53:35

Tags for this article:

Click the tags to see associated articles and topics

Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201, a HER2-Targeted CAR .... View article details on hiswai:

Excerpt

... and multiple HER2-directed agents, including monoclonal antibodies, antibody-drug conjugates, and small molecule tyrosine kinase inhibitors ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up